Artificial Intelligence in Perioperative Medicine: A Proposed Common Language With Applications to FDA-Approved Devices
As implementation of artificial intelligence grows more prevalent in perioperative medicine, a clinician's ability to distinguish differentiating aspects of these algorithms is critical. There are currently numerous marketing and technical terms to describe these algorithms with little standard...
Main Authors: | Ryan L. Melvin, Matthew G. Broyles, Elizabeth W. Duggan, Sonia John, Andrew D. Smith, Dan E. Berkowitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Digital Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fdgth.2022.872675/full |
Similar Items
-
FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
by: Carla Rizzo, et al.
Published: (2023-04-01) -
Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01) -
The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
by: Timothée Olivier, et al.
Published: (2022-04-01) -
Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
by: Rekha Tamatam, et al.
Published: (2023-02-01) -
FDA Approvals of Biologics in 2022
by: Alexander C. Martins, et al.
Published: (2023-05-01)